United States: In A Regulatory "One-Two," FDA Modifies Terms Of Oversight Concerning Homeopathic Drugs

Duane Morris LLP

Late last week, the FDA-in denying a citizen petition and issuing two Federal Register notices-modified published guidance on the manufacture and distribution of homeopathic drugs.